molecule
stringlengths 1
990
| caption
stringlengths 5
2.09k
|
|---|---|
COCC1(F)CC1 | It impacts alzheimer's treatment. The molecule is a bace inhibitor and belongs to the neurological treatment class of molecules. |
COCC1(F)CC1 | The molecule is a bace inhibitor that impacts both alzheimer's treatment and neurological treatment. |
COCC1(F)CC1 | The molecule is a bace inhibitor and neurological treatment, and it impacts alzheimer's treatment. |
COCC1(F)CC1 | The molecule is a bace inhibitor and belongs to the neurological treatment class of molecules, with the characteristic of being alzheimer's treatment. |
COCC1(F)CC1 | The molecule is a bace inhibitor and belongs to the alzheimer's treatment class of molecules, with the characteristic of being neurological treatment. |
CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a inflammatory, a energy source, and a energy storage. The molecule is a fat storage that impacts obesity, pancreatitis, and metabolic syndrome. The molecule is a membrane stabilizer and nutrient, belonging to the thyroxine treatment class of molecules, and impacts atherosclerosis, cardiovascular disease, and cancer. |
CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a fat storage that impacts pancreatitis, cancer, and thyroxine treatment. The molecule is a inflammatory and a energy source, impacting both atherosclerosis and metabolic syndrome. The molecule is a membrane stabilizer, energy storage, nutrient that impacts obesity and cardiovascular disease. |
CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a inflammatory and a membrane stabilizer, impacting both metabolic syndrome and cardiovascular disease. The molecule is a energy source, a thyroxine treatment, and a fat storage, and it impacts obesity. The molecule is a nutrient and a energy storage that impacts atherosclerosis, cancer, and pancreatitis. |
CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a inflammatory, membrane stabilizer, fat storage, nutrient, energy source that impacts metabolic syndrome. It has an effect on cancer, impacting both atherosclerosis and cardiovascular disease. The molecule is a energy storage and belongs to the thyroxine treatment class of molecules, impacting both pancreatitis and obesity. |
CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a inflammatory, fat storage, energy storage that has an effect on cancer and impacts obesity. The molecule is a energy source and a membrane stabilizer that impacts cardiovascular disease, pancreatitis, and atherosclerosis. The molecule is a nutrient and thyroxine treatment, and it impacts metabolic syndrome. |
CCC(C)CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC | The molecule is a energy storage, thyroxine treatment, membrane stabilizer that impacts atherosclerosis, obesity, and cardiovascular disease. The molecule is a energy source, fat storage, inflammatory, nutrient that impacts pancreatitis and metabolic syndrome. It has an effect on cancer. |
CCC(C)CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC | The molecule is a energy source, energy storage, thyroxine treatment that impacts pancreatitis, metabolic syndrome, and cardiovascular disease. The molecule is a inflammatory, fat storage, membrane stabilizer that impacts obesity, cancer, and atherosclerosis. The molecule is a nutrient. |
CCC(C)CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC | The molecule is a energy source, a nutrient, and a fat storage, and it impacts metabolic syndrome. The molecule is a membrane stabilizer that affects cancer by impacting both atherosclerosis and cardiovascular disease. The molecule is a energy storage and a inflammatory that impacts obesity, pancreatitis, and thyroxine treatment. |
CCC(C)CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC | The molecule is a membrane stabilizer, energy storage, energy source that belongs to the thyroxine treatment class of molecules and impacts atherosclerosis. The molecule is a inflammatory that impacts cardiovascular disease, pancreatitis, and obesity. The molecule is a fat storage and a nutrient, with effects on cancer and impacts on metabolic syndrome. |
CCC(C)CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC | The molecule is a energy storage that impacts atherosclerosis. The molecule is a inflammatory, fat storage, energy source that impacts metabolic syndrome and obesity. The molecule is a nutrient and a membrane stabilizer, which impacts pancreatitis, cancer, and cardiovascular disease, and is characterized as thyroxine treatment. |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC[C@@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCCCC | It impacts parkinson's disease, colorectal cancer, breast cancer, and alzheimer's disease. It has an effect on stomach cancer, and impacts diabetes mellitus, cardiovascular disease, and seizure. |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC[C@@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCCCC | It has an effect on breast cancer, and impacts diabetes mellitus, parkinson's disease, and cardiovascular disease. It has an effect on colorectal cancer, and impacts alzheimer's disease, stomach cancer, and seizure. |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC[C@@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCCCC | It has an effect on both breast cancer and colorectal cancer, and impacts seizure. It impacts stomach cancer, cardiovascular disease, alzheimer's disease, diabetes mellitus, and parkinson's disease. |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC[C@@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCCCC | It has an effect on breast cancer, and impacts stomach cancer, cardiovascular disease, parkinson's disease, and diabetes mellitus. It has an effect on colorectal cancer, impacting both seizure and alzheimer's disease. |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC[C@@H](O)/C=C\C=C\C=C\[C@@H](O)C/C=C\CCCCC | It has an effect on stomach cancer, impacting both seizure and diabetes mellitus. It has an effect on colorectal cancer, and impacts breast cancer, cardiovascular disease, parkinson's disease, and alzheimer's disease. |
C=C1C[C@]23C[C@@]1(O)[C@@H](O)C[C@H]2[C@@]12CCC[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O | The molecule is a emulsifier, a surfactant, and a membrane stabilizer. The molecule is a nutrient, a energy storage, and a energy source. |
C=C1C[C@]23C[C@@]1(O)[C@@H](O)C[C@H]2[C@@]12CCC[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O | The molecule is a emulsifier, membrane stabilizer, nutrient, energy storage, surfactant. The molecule is a energy source. |
C=C1C[C@]23C[C@@]1(O)[C@@H](O)C[C@H]2[C@@]12CCC[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O | The molecule is a nutrient, energy source, membrane stabilizer, surfactant, emulsifier, energy storage. |
C=C1C[C@]23C[C@@]1(O)[C@@H](O)C[C@H]2[C@@]12CCC[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O | The molecule is a membrane stabilizer, emulsifier, energy source, energy storage, nutrient, surfactant. |
C=C1C[C@]23C[C@@]1(O)[C@@H](O)C[C@H]2[C@@]12CCC[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O | The molecule is a energy source, nutrient, membrane stabilizer, emulsifier, energy storage, surfactant. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and aging. The molecule is a stabilizing cytochrome oxidase and stabilizing mitochondrial structure, and it impacts barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both tangier disease and diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts tangier disease, barth syndrome, and aging. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure that impacts aging, tangier disease, and diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a cholesterol translocation that impacts tangier disease, aging, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing cytochrome oxidase that impacts tangier disease. The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure. It impacts aging, diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation that impacts aging. The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a apoptosis that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis, a stabilizing mitochondrial structure, and a proton trap for oxidative phosphorylation. The molecule is a stabilizing cytochrome oxidase that impacts tangier disease, barth syndrome, and aging. |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | It impacts aging, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis. The molecule is a stabilizing mitochondrial structure that impacts both non-alcoholic fatty liver disease and barth syndrome. |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation, impacting both aging and diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts aging. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts aging. The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both barth syndrome and diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | The molecule is a cholesterol translocation that impacts both barth syndrome and tangier disease. The molecule is a stabilizing mitochondrial structure and apoptosis, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both aging and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation, a stabilizing cytochrome oxidase, and a cholesterol translocation. The molecule is a stabilizing mitochondrial structure that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and tangier disease. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | The molecule is a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and tangier disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and barth syndrome. The molecule is both a cholesterol translocation and a stabilizing mitochondrial structure. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure that impacts both aging and tangier disease. The molecule is a apoptosis and a cholesterol translocation, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts barth syndrome. |
CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a thyroxine treatment and a fat storage, impacting both atherosclerosis and metabolic syndrome. |
CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | The molecule is a fat storage, nutrient, thyroxine treatment that impacts pancreatitis and atherosclerosis. It impacts both metabolic syndrome and cardiovascular disease. |
CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | The molecule is a fat storage that impacts cardiovascular disease, metabolic syndrome, and pancreatitis. The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting atherosclerosis. |
CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | The molecule is a nutrient and fat storage, and it impacts atherosclerosis. It impacts cardiovascular disease, thyroxine treatment, pancreatitis, and metabolic syndrome. |
CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts pancreatitis, cardiovascular disease, and atherosclerosis. It impacts metabolic syndrome. |
CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts barth syndrome, aging, and diabetic heart disease. |
CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a cholesterol translocation and a apoptosis that impacts tangier disease, aging, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both aging and non-alcoholic fatty liver disease. The molecule is a apoptosis that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is both a stabilizing cytochrome oxidase and a cholesterol translocation. |
CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a apoptosis that impacts both aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing mitochondrial structure, and it impacts tangier disease. |
CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts non-alcoholic fatty liver disease and aging. |
CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a membrane stabilizer and a energy source, it impacts atherosclerosis, and is thyroxine treatment. The molecule is a inflammatory and a fat storage, impacting both pancreatitis and metabolic syndrome. The molecule is a energy storage and a nutrient that impacts obesity, cardiovascular disease, and cancer. |
CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a membrane stabilizer, fat storage, and energy storage that has an effect on cancer and impacts both atherosclerosis and obesity. The molecule is a energy source and nutrient, and it impacts cardiovascular disease. The molecule is a inflammatory and a thyroxine treatment, impacting both metabolic syndrome and pancreatitis. |
CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a fat storage and energy source, and it impacts atherosclerosis. The molecule is a nutrient, thyroxine treatment, membrane stabilizer that impacts obesity and pancreatitis. The molecule is a inflammatory and a energy storage that impacts metabolic syndrome, cancer, and cardiovascular disease. |
CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C | It impacts both metabolic syndrome and pancreatitis. The molecule is a energy storage and a nutrient, which has an effect on cancer and impacts both cardiovascular disease and atherosclerosis. The molecule is a inflammatory, fat storage, energy source, thyroxine treatment, membrane stabilizer that impacts obesity. |
CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C | It impacts metabolic syndrome. The molecule is a fat storage, nutrient, energy source that impacts atherosclerosis, pancreatitis, and obesity. The molecule is a membrane stabilizer, energy storage, inflammatory, belonging to the thyroxine treatment class of molecules, and it has an effect on cancer as well as impacts cardiovascular disease. |
CC1(C)OCC(CCCO)CO1 | It belongs to the liquid crystal class of molecules. |
CC1(C)OCC(CCCO)CO1 | The molecule is a liquid crystal. |
CC1(C)OCC(CCCO)CO1 | It belongs to the liquid crystal class of molecules. |
CC1(C)OCC(CCCO)CO1 | The molecule is a liquid crystal. |
CC1(C)OCC(CCCO)CO1 | It belongs to the liquid crystal class of molecules. |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. It impacts tangier disease. |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts non-alcoholic fatty liver disease and aging. It impacts barth syndrome. |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a apoptosis that impacts aging. The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and barth syndrome. |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a food additive, a emulsifier, and a nutritional supplement. The molecule is a stabilizing mitochondrial structure, a apoptosis, and a energy storage, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, and a membrane stabilizer, and it impacts barth syndrome. The molecule is a energy source and a surfactant, it impacts aging, and is smooth. The molecule is a stabilizing cytochrome oxidase that impacts both tangier disease and diabetic heart disease. |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a apoptosis and a emulsifier, impacting both barth syndrome and tangier disease. The molecule is a energy source, a stabilizing mitochondrial structure, and a cholesterol translocation. The molecule is a food additive, stabilizing cytochrome oxidase, energy storage, membrane stabilizer. The molecule is a proton trap for oxidative phosphorylation and smooth, and it impacts diabetic heart disease. The molecule is a nutritional supplement and a surfactant, impacting both aging and non-alcoholic fatty liver disease. |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a membrane stabilizer, a stabilizing cytochrome oxidase, and a energy source that impacts both barth syndrome and aging, and is smooth. The molecule is a surfactant, food additive, apoptosis, nutritional supplement that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy storage, stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation, emulsifier that impacts tangier disease. |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a surfactant, a emulsifier, and smooth. The molecule is a apoptosis and nutritional supplement, and it impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, membrane stabilizer, food additive. The molecule is a energy storage, a energy source, and a proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease. |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a surfactant and a food additive, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a stabilizing mitochondrial structure, nutritional supplement, proton trap for oxidative phosphorylation, energy source that impacts aging. The molecule is a energy storage, a stabilizing cytochrome oxidase, and a cholesterol translocation, and it impacts diabetic heart disease. The molecule is a emulsifier, membrane stabilizer, apoptosis that impacts tangier disease and barth syndrome. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a proton trap for oxidative phosphorylation that impacts both tangier disease and diabetic heart disease. The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, and a apoptosis, and it impacts aging. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and barth syndrome. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a cholesterol translocation that impacts both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC | The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and diabetic heart disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome. |
CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | The molecule is a apoptosis that impacts both barth syndrome and aging. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and cholesterol translocation, and it impacts tangier disease. |
CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | The molecule is a cholesterol translocation and a apoptosis, impacting both aging and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts barth syndrome. |
CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | The molecule is a apoptosis and a stabilizing mitochondrial structure, impacting both aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and tangier disease. The molecule is a proton trap for oxidative phosphorylation that impacts barth syndrome. |
CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | It impacts tangier disease, non-alcoholic fatty liver disease, diabetic heart disease, barth syndrome, and aging. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation. |
CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure, impacting both aging and tangier disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and barth syndrome. It impacts non-alcoholic fatty liver disease. |
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1 | The molecule is a orexin type 2 receptor agonist. |
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1 | The molecule is a orexin type 2 receptor agonist. |
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1 | It belongs to the orexin type 2 receptor agonist class of molecules. |
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1 | It belongs to the orexin type 2 receptor agonist class of molecules. |
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1 | It belongs to the orexin type 2 receptor agonist class of molecules. |
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a fat storage that belongs to the thyroxine treatment class of molecules, impacting metabolic syndrome, pancreatitis, and cardiovascular disease. The molecule is a nutrient that impacts atherosclerosis. |
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a nutrient that impacts both atherosclerosis and metabolic syndrome. The molecule is a thyroxine treatment and a fat storage, impacting both cardiovascular disease and pancreatitis. |
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts pancreatitis, cardiovascular disease, and atherosclerosis. It impacts metabolic syndrome. |
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a thyroxine treatment that impacts metabolic syndrome. The molecule is a fat storage and a nutrient that impacts cardiovascular disease, pancreatitis, and atherosclerosis. |
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a nutrient that impacts metabolic syndrome, atherosclerosis, and pancreatitis. The molecule is a fat storage and thyroxine treatment, and it impacts cardiovascular disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | It impacts barth syndrome, aging, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase. The molecule is a cholesterol translocation that impacts diabetic heart disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, tangier disease, and aging. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | The molecule is a cholesterol translocation that impacts tangier disease, aging, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and non-alcoholic fatty liver disease. |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts diabetic heart disease and non-alcoholic fatty liver disease. |
CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a surfactant, food additive, cholesterol translocation, stabilizing mitochondrial structure. The molecule is a energy source and smooth, impacting aging, barth syndrome, and diabetic heart disease. The molecule is a nutritional supplement, a membrane stabilizer, and a stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, emulsifier, energy storage, apoptosis that impacts tangier disease. |
CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a nutritional supplement, a proton trap for oxidative phosphorylation, and a surfactant, and it impacts aging. The molecule is a emulsifier and a energy storage, it impacts barth syndrome, and is smooth. The molecule is a cholesterol translocation, membrane stabilizer, energy source, stabilizing mitochondrial structure. The molecule is a apoptosis and a food additive, impacting both tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease. |
CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a emulsifier. The molecule is a apoptosis, a surfactant, and a nutritional supplement, and it impacts non-alcoholic fatty liver disease. The molecule is a energy source that impacts tangier disease, aging, and barth syndrome. The molecule is a food additive, a stabilizing mitochondrial structure, and a membrane stabilizer, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation, energy storage, and smooth. |
CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation, nutritional supplement, emulsifier, apoptosis, and smooth. The molecule is a stabilizing cytochrome oxidase, energy storage, cholesterol translocation, food additive that impacts tangier disease. The molecule is a membrane stabilizer and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy source and a surfactant, impacting both barth syndrome and aging. |
CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | The molecule is a apoptosis and energy storage, and it impacts non-alcoholic fatty liver disease. The molecule is a surfactant, a emulsifier, and a cholesterol translocation, and it impacts barth syndrome. The molecule is a nutritional supplement that impacts both aging and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a food additive, it impacts diabetic heart disease, and is smooth. The molecule is a stabilizing mitochondrial structure, energy source, membrane stabilizer, stabilizing cytochrome oxidase. |